NO313290B1 - Fremgangsmåte for fremstilling av substituert tiazolidindion - Google Patents

Fremgangsmåte for fremstilling av substituert tiazolidindion Download PDF

Info

Publication number
NO313290B1
NO313290B1 NO19993949A NO993949A NO313290B1 NO 313290 B1 NO313290 B1 NO 313290B1 NO 19993949 A NO19993949 A NO 19993949A NO 993949 A NO993949 A NO 993949A NO 313290 B1 NO313290 B1 NO 313290B1
Authority
NO
Norway
Prior art keywords
borohydride
formula
compound
methyl
reducing agent
Prior art date
Application number
NO19993949A
Other languages
English (en)
Norwegian (no)
Other versions
NO993949D0 (no
NO993949L (no
Inventor
Robert Gordon Giles
Norman John Lewis
Stephen Moore
Colin Ripley Pool
John Kirby Quick
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO313290(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9703310.4A external-priority patent/GB9703310D0/en
Priority claimed from GBGB9703338.5A external-priority patent/GB9703338D0/en
Priority claimed from GBGB9703334.4A external-priority patent/GB9703334D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO993949D0 publication Critical patent/NO993949D0/no
Publication of NO993949L publication Critical patent/NO993949L/no
Publication of NO313290B1 publication Critical patent/NO313290B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO19993949A 1997-02-18 1999-08-17 Fremgangsmåte for fremstilling av substituert tiazolidindion NO313290B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9703310.4A GB9703310D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703338.5A GB9703338D0 (en) 1997-02-18 1997-02-18 Novel process
GBGB9703334.4A GB9703334D0 (en) 1997-02-18 1997-02-18 Novel compounds
PCT/EP1998/000818 WO1998037073A1 (en) 1997-02-18 1998-02-13 Process for the preparation of substituted thiazolidinedione

Publications (3)

Publication Number Publication Date
NO993949D0 NO993949D0 (no) 1999-08-17
NO993949L NO993949L (no) 1999-09-07
NO313290B1 true NO313290B1 (no) 2002-09-09

Family

ID=27268725

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19993949A NO313290B1 (no) 1997-02-18 1999-08-17 Fremgangsmåte for fremstilling av substituert tiazolidindion
NO20023937A NO20023937D0 (no) 1997-02-18 2002-08-19 Fremgangsmåte for fremstilling av substituert tiazolidindion

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20023937A NO20023937D0 (no) 1997-02-18 2002-08-19 Fremgangsmåte for fremstilling av substituert tiazolidindion

Country Status (29)

Country Link
EP (2) EP0970063A1 (tr)
JP (2) JP2001514619A (tr)
KR (1) KR20000071138A (tr)
CN (1) CN1252065A (tr)
AP (1) AP1359A (tr)
AR (1) AR011447A1 (tr)
AU (1) AU6622398A (tr)
BG (1) BG64311B1 (tr)
BR (1) BR9807395A (tr)
CA (1) CA2281695C (tr)
CZ (1) CZ296272B6 (tr)
DZ (1) DZ2430A1 (tr)
EA (1) EA199900754A1 (tr)
HU (1) HUP0001459A3 (tr)
ID (1) ID22222A (tr)
IL (1) IL131392A (tr)
IN (1) IN188379B (tr)
MA (1) MA24475A1 (tr)
MY (1) MY129475A (tr)
NO (2) NO313290B1 (tr)
NZ (1) NZ337179A (tr)
OA (1) OA11148A (tr)
PE (1) PE71899A1 (tr)
PL (1) PL195482B1 (tr)
SK (2) SK285979B6 (tr)
TR (1) TR199902019T2 (tr)
TW (1) TWI222446B (tr)
UY (1) UY24886A1 (tr)
WO (1) WO1998037073A1 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
GB9723295D0 (en) 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
ES2203453T3 (es) * 1999-04-23 2004-04-16 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
FR2820741A1 (fr) * 2001-02-14 2002-08-16 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR2820742B1 (fr) * 2001-02-14 2005-03-11 Ppg Sipsy Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
OA12963A (en) 2002-11-22 2006-10-13 Smithkline Beecham Corp Novel chemical compounds.
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
CA2566352A1 (en) * 2004-05-12 2005-11-17 Medichem S.A. Process for the preparation of rosiglitazone
CZ297266B6 (cs) * 2004-09-10 2006-10-11 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
JPH0377875A (ja) * 1989-08-18 1991-04-03 Kaken Pharmaceut Co Ltd チアゾリジン‐2,4‐ジオン誘導体およびその製造法
EP0454501B1 (en) * 1990-04-27 2001-09-05 Sankyo Company Limited Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
US5585495A (en) * 1991-12-20 1996-12-17 The Upjohn Company Reduction method for substituted 5-methylene-thiazolidinediones
JPH08157473A (ja) * 1994-10-06 1996-06-18 Nissan Chem Ind Ltd ピラゾール系チアゾリジン類
JPH08217717A (ja) * 1995-02-10 1996-08-27 Sumitomo Chem Co Ltd 環状ケトン系化合物、その製造法およびそれを有効成分とするゴキブリ誘引剤
NZ308228A (en) * 1995-05-31 1999-11-29 Sumitomo Pharma Substituted 1,8-naphthyridine derivatives

Also Published As

Publication number Publication date
ID22222A (id) 1999-09-16
JP2009149616A (ja) 2009-07-09
NO20023937D0 (no) 2002-08-19
IN188379B (tr) 2002-09-14
IL131392A (en) 2005-07-25
MA24475A1 (fr) 1998-10-01
JP2001514619A (ja) 2001-09-11
SK112099A3 (en) 2000-05-16
CZ292499A3 (cs) 2000-02-16
CA2281695A1 (en) 1998-08-27
PL335163A1 (en) 2000-04-10
BG103735A (en) 2000-06-30
UY24886A1 (es) 2001-08-27
OA11148A (en) 2003-04-16
AP1359A (en) 2004-12-02
NZ337179A (en) 2001-07-27
AP9901626A0 (en) 1999-09-30
BR9807395A (pt) 2000-03-14
CZ296272B6 (cs) 2006-02-15
NO993949D0 (no) 1999-08-17
SK287512B6 (sk) 2010-12-07
HUP0001459A3 (en) 2002-11-28
WO1998037073A1 (en) 1998-08-27
EP1770092A1 (en) 2007-04-04
AU6622398A (en) 1998-09-09
NO20023937L (no) 1999-09-07
EP0970063A1 (en) 2000-01-12
IL131392A0 (en) 2001-01-28
PE71899A1 (es) 1999-09-15
DZ2430A1 (fr) 2003-01-11
AR011447A1 (es) 2000-08-16
CN1252065A (zh) 2000-05-03
TWI222446B (en) 2004-10-21
KR20000071138A (ko) 2000-11-25
TR199902019T2 (tr) 1999-12-21
PL195482B1 (pl) 2007-09-28
NO993949L (no) 1999-09-07
BG64311B1 (bg) 2004-09-30
HUP0001459A2 (hu) 2000-10-28
SK285979B6 (sk) 2007-12-06
CA2281695C (en) 2006-12-12
MY129475A (en) 2007-04-30
EA199900754A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
JP2009149616A (ja) 置換チアゾリジンジオンの製造方法
SK14593A3 (en) Sulfonylbenzyl substituted pyridones
EP0760812A1 (en) Pharmaceutical diketopiperazine compounds
WO1997012866A1 (en) Bis-heteroarylylmethoxyphenylketone derivatives as inhibitors of leukotriene biosynthesis
IL108636A (en) Multi-Transformed History of 2-Amino-Thiazole, Preparation and Pharmaceutical Preparations Containing Them
CZ251992A3 (en) Methanoanthracene derivatives, process of their preparation and pharmaceutical compositions in which said derivatives are comprised
EP1028960B1 (en) Process for the preparation of thiazolidinedione derivatives
CZ283485B6 (cs) Způsob výroby látek, antagonisujících receptory fibrinogenu
US6632947B2 (en) Process for the preparation of substituted thiazolidinedione
KR920003927B1 (ko) 헤테로사이클릭구아니딘 5ht_3 길항물질
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
WO1988001270A1 (en) Pyridopyrimidinediones
NO781051L (no) Kinazolinderivater.
AU774839B2 (en) Process for the preparation of substituted thiazolidinedione
CZ301422B6 (cs) Zpusob prípravy alfa´-chlorketonu
WO2005058827A1 (en) Process for the synthesis of pioglitazone hydrogen chloride
US20020120150A1 (en) Process for the preparation of thiazolidinedione derivatives
JPS6045577A (ja) 2−アザビシクロ〔2.2.2〕オクタン誘導体
MXPA99007656A (en) Process for the preparation of substituted thiazolidinedione
RU2123000C1 (ru) О-арильные эфиры морфинанов, фармацевтическая композиция
SA98190168B1 (ar) عملية لتحضيرمشتقات thiazolidinedion مستبدلة
JPS5951534B2 (ja) 2−アミノ−3−ヒドロキシピリジン誘導体の製造法
CA2077238A1 (en) N-phenyl-n'-alkyl-n'-pyridylmethyl- bis-diamino-5-methylene-1,3-dioxane- 4,6-dione inhibitors of acyl-coa: cholesterol-acyl transferase
CZ11999A3 (cs) Způsob výroby naftyridonů a meziprodukty

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees